Market Cap 19,000.00
Revenue (ttm) 0.00
Net Income (ttm) -4.49M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 25,100
Avg Vol 42,804
Day's Range N/A - N/A
Shares Out 94.54M
Stochastic %K 0%
Beta 13.85
Analysts Strong Buy
Price Target N/A

Company Profile

Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of products for the aging population. Its lead drug candidate is Fexapotide Triflutate (NX-1207) for the treatment of benign prostatic hyperplasia and low-grade localized prostate cancer, as well as hepatocellular carcinoma. The company also offers NicAlert, a test for determining smoking status; and TobacAlert, a test for detecting second-hand smoke exposure. In addition, it develops drugs for...

Industry: Biotechnology
Sector: Healthcare
Phone: 800 936 9669
Fax: 514 332 2227
Website: nymox.com
Address:
Bay & Deveaux Streets, 2nd Floor, Nassau, Bahamas
usa2018
usa2018 Aug. 14 at 2:55 PM
$NYMXF 110 shares have traded at .0002. Looks like the New Board Members are starting to load up. The question is will they be selling when the stock price rockets up to .002?
1 · Reply
usa2018
usa2018 Aug. 12 at 1:42 PM
$NYMXF His name is on the SEC Filing to be a Director of Nymox. Looks like Passeraser a frequent poster on this Board supporting Dr A and the way he has managed Nymox will be joining the Board of Directors. If the new Board Members which average 73 years in age like the way Dr A manages Nymox I would think the direction Nymox has taken over the past 3 years will accelerate. Can the stock price possibly get lower to possibly .0000002 from .0002? On the Proxy Card checking “Withhold” as a vote choice looks like a great option.
1 · Reply
IPGreen
IPGreen Aug. 11 at 3:28 PM
$NYMXF other than the loss of Mr Robinson, it looks like we are really upgrading our BOD
2 · Reply
usa2018
usa2018 Aug. 11 at 2:44 PM
$NYMXF Dr a has mis-managed Nymox and the Drug Development in deviating from the FDA instructions and most likely altering the Data so even Dr Claus Roehrborn could not figure it out. The result 8 REJECTIONS, a stock price of 2-10,000th of a penny, (0002) but a boat load of Loyalists, probably his family, who still honor and love him. So, with new Board Members desperately needed you’d think Dr A would find a well-known Urologist to join the Leadership Team and lead the way. Nope, Dr A finds a Veterinarian! Dr Kresimir Pucaj, DVM a 73-year-old Canadian Veterinarian to lead the Medical Process with the FDA and the other Jurisdictions that have issued Rejections. Is Dr A joking? There has been no approval for the Drug in Humans, so it looks like Dr A is he now pivoting to animals? I’m now waiting for the SPCA to issue a Refuse To File so as to save all animals.
1 · Reply
svseeker3000
svseeker3000 Aug. 8 at 9:38 PM
$NYMXF https://www.sec.gov/Archives/edgar/data/1018735/000164033426001291/nymox_6k.htm
0 · Reply
itaintwhatyou
itaintwhatyou Aug. 8 at 11:33 AM
$NYMXF See new 6K / BOD meeting to elect new Directors
0 · Reply
usa2018
usa2018 Aug. 7 at 3:16 PM
$NYMXF Big news. I’m now hearing the Nymox share price drop to .0002 was the result of the Application for Approval that was submitted to Gilligan’s Island. The Professor wrote that even though The Skipper and Gilligan both got The Shot in their ass, the submission by Dr A for Approval was incomplete, poorly organized, or lacked critical safety, efficacy, or quality data. This is from the Professor who sure is not as knowledgeable as the FDA Experts. Can anybody think of a deserted island or 3rd World County that might give and approval like Roatan Island did? We need to get the stock price up to at least .002! But don't worry everything is ok with Nymox and Dr A......
0 · Reply
usa2018
usa2018 Aug. 7 at 12:57 PM
$NYMXF at a stock price of .0002 does anybody know how many shares it will take to convert the Loan Payables to Stock Shares? Will the Dilution be a negative for Dr A's Company?
0 · Reply
usa2018
usa2018 Aug. 6 at 3:26 PM
$NYMXF The OTC Markets Web Site is reporting last trade of 1,101 shares of Nymox was at .0002. That’s a total value of .2202 cents. The Dr A Loyalists fought off that Ascella deal so they cold get a better price. That price is here so LOAD UP at this great price, .0002 You’re welcome
1 · Reply
usa2018
usa2018 Aug. 5 at 6:31 PM
$NYMXF I'm constantly told things are good with Nymox, Dr A and there is nothing to worry about. So maybe I should believe in Miracles too! Do you think the 400 shares traded today was Roche, J&J or some other Big Pharma getting a position to start a merger? So exciting.......
1 · Reply
Latest News on NYMXF
No data available.
usa2018
usa2018 Aug. 14 at 2:55 PM
$NYMXF 110 shares have traded at .0002. Looks like the New Board Members are starting to load up. The question is will they be selling when the stock price rockets up to .002?
1 · Reply
usa2018
usa2018 Aug. 12 at 1:42 PM
$NYMXF His name is on the SEC Filing to be a Director of Nymox. Looks like Passeraser a frequent poster on this Board supporting Dr A and the way he has managed Nymox will be joining the Board of Directors. If the new Board Members which average 73 years in age like the way Dr A manages Nymox I would think the direction Nymox has taken over the past 3 years will accelerate. Can the stock price possibly get lower to possibly .0000002 from .0002? On the Proxy Card checking “Withhold” as a vote choice looks like a great option.
1 · Reply
IPGreen
IPGreen Aug. 11 at 3:28 PM
$NYMXF other than the loss of Mr Robinson, it looks like we are really upgrading our BOD
2 · Reply
usa2018
usa2018 Aug. 11 at 2:44 PM
$NYMXF Dr a has mis-managed Nymox and the Drug Development in deviating from the FDA instructions and most likely altering the Data so even Dr Claus Roehrborn could not figure it out. The result 8 REJECTIONS, a stock price of 2-10,000th of a penny, (0002) but a boat load of Loyalists, probably his family, who still honor and love him. So, with new Board Members desperately needed you’d think Dr A would find a well-known Urologist to join the Leadership Team and lead the way. Nope, Dr A finds a Veterinarian! Dr Kresimir Pucaj, DVM a 73-year-old Canadian Veterinarian to lead the Medical Process with the FDA and the other Jurisdictions that have issued Rejections. Is Dr A joking? There has been no approval for the Drug in Humans, so it looks like Dr A is he now pivoting to animals? I’m now waiting for the SPCA to issue a Refuse To File so as to save all animals.
1 · Reply
svseeker3000
svseeker3000 Aug. 8 at 9:38 PM
$NYMXF https://www.sec.gov/Archives/edgar/data/1018735/000164033426001291/nymox_6k.htm
0 · Reply
itaintwhatyou
itaintwhatyou Aug. 8 at 11:33 AM
$NYMXF See new 6K / BOD meeting to elect new Directors
0 · Reply
usa2018
usa2018 Aug. 7 at 3:16 PM
$NYMXF Big news. I’m now hearing the Nymox share price drop to .0002 was the result of the Application for Approval that was submitted to Gilligan’s Island. The Professor wrote that even though The Skipper and Gilligan both got The Shot in their ass, the submission by Dr A for Approval was incomplete, poorly organized, or lacked critical safety, efficacy, or quality data. This is from the Professor who sure is not as knowledgeable as the FDA Experts. Can anybody think of a deserted island or 3rd World County that might give and approval like Roatan Island did? We need to get the stock price up to at least .002! But don't worry everything is ok with Nymox and Dr A......
0 · Reply
usa2018
usa2018 Aug. 7 at 12:57 PM
$NYMXF at a stock price of .0002 does anybody know how many shares it will take to convert the Loan Payables to Stock Shares? Will the Dilution be a negative for Dr A's Company?
0 · Reply
usa2018
usa2018 Aug. 6 at 3:26 PM
$NYMXF The OTC Markets Web Site is reporting last trade of 1,101 shares of Nymox was at .0002. That’s a total value of .2202 cents. The Dr A Loyalists fought off that Ascella deal so they cold get a better price. That price is here so LOAD UP at this great price, .0002 You’re welcome
1 · Reply
usa2018
usa2018 Aug. 5 at 6:31 PM
$NYMXF I'm constantly told things are good with Nymox, Dr A and there is nothing to worry about. So maybe I should believe in Miracles too! Do you think the 400 shares traded today was Roche, J&J or some other Big Pharma getting a position to start a merger? So exciting.......
1 · Reply
IPGreen
IPGreen Jul. 28 at 6:40 PM
$NYMXF I wonder if that volume is one transaction
0 · Reply
usa2018
usa2018 Jul. 24 at 5:40 PM
$NYMXF I'm expecting Legal Action by Shareholders againest the Dr A, His Estate, along with The Mark's , Director Robinson, Estate for huge damages due to the Fraud of Dr A. causing the Loss of Value especially when Ascella was going to save the Company till Dr A caused the distraction. That's where the deep pockets are so get ready to sign on to a Class Action Suit and recoup some of the losses. We will get some money back!
4 · Reply
usa2018
usa2018 Jul. 24 at 12:39 PM
$NYMXF We finally showed Ascella who is in charge and who has the best business skills. Lets take a big bow that we pushed back on the Restore Group and the Ascella Proposal of 2023. Imagine Ascella having the nerve to think we would jump at their offer of putting Millions of Dollars in with no recourse to redo the Trials to FDA Standards. They are just Pathetic. So Thankful we have Dr A and Very Loyal Shareholders who knew Dr A could lead the Company to the Finish Line. Nymox now trading on the Lowest Tier Expert OTC Exchange and trading at a Half a Cent or Lower I think we made the Finish Line. HIP HIP HOORAY….HIP HIT HOORAY FOR Dr A and THE LOYAL SHAREHOLDERS WHO GOT US HERE…..HIP HIP HORRAY
0 · Reply
HFH_Inc
HFH_Inc Jul. 23 at 5:25 PM
$NYMXF This is one Zimbabwe approval away from reaching one penny per share. It's coming. Exciting times in here!
0 · Reply
usa2018
usa2018 Jul. 22 at 12:56 PM
$NYMXF Now that Nymox last trade was for .005, a half a cent, here is photo. There are 2 things missing from this photo. 1. Dr A inside 2. Door closed and locked.
0 · Reply
giannobes14
giannobes14 Jul. 21 at 9:45 PM
$NYMXF any other news after June 2, other than USA's posts?
2 · Reply
usa2018
usa2018 Jul. 21 at 7:46 PM
$NYMXF Back in Nov/Dec of 2023 Dr A said he'd have a Shareholder Meeting promptly. With the stock now at .005, a half a cent, does that mean there probably will not be a Meeting? We are so much better off now then we would have been with Ascella putting in Millions of Dollars and redoing the Trials correctly.
0 · Reply
usa2018
usa2018 Jul. 21 at 6:53 PM
$NYMXF Nymox Pharmaceutical Corporation (NYMXF) Per Yahoo Finance the last trade was for: .0056 Finally at the bottom of the barrel. Thank you Dr A, Master Fraudster
0 · Reply
usa2018
usa2018 Jul. 21 at 2:34 PM
$NYMXF People leaving the Island Roatan for a long row boat journey back home after learning that there is no Nymox Medicines available. There big question was why did Dr A lie?
0 · Reply
usa2018
usa2018 Jul. 14 at 12:53 PM
$NYMXF Honest Abe Lincoln will never be confused with Dr. A! I was curious about the Top-Notch Medical Treatment on the Island of Roatan, so I called GARM. I was told they had no idea when the treatment with the Nymox Medicine would be available and to call back in a few weeks. I’m sure there will not be One Treatment on this Island of Miracles due to Nymox not having any product and no money to even make a short run. A short run would probably cost up to $1,000,000 or more and there is no money since The Mark, Mr. Robinson, has died. Why would Dr A put out this Fraudulent Press Release? So, can the Dr A Loyalist let us know how this treatment is going to roll out on Roatan? The phone number for GARM is 1-305-848-0144
0 · Reply
usa2018
usa2018 Jul. 10 at 12:54 PM
$NYMXF Wow...... Now I know why Dr A could not get an approval!
1 · Reply
usa2018
usa2018 Jul. 7 at 6:28 PM
1 · Reply